Wenxing Qin, Jian Zhang, Wantao Chen, Sihua Wang, Rongrong Li, Ruiguang Zhang, Jing Li, Baorong Song, Qianxiang Zhou, Chunlan Dong, Liangbao Lai, Shengtang Ma, Yanliang Zhang, Tony Zhang. "Phase 1/2 study of TSN222, a novel dual action tumor immune agonist (DATIA), in patients with advanced malignancies.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e14572